Erectile dysfunction and low testosterone: Cause or an effect?

Canadian Journal of Urology

Volumn 17, Issue , 2010, Pages 2-11

  Barkin, Jack ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diagnosis; Erectile dysfunction; Hypogonadism; Low testosterone; Management; metabolic syndrome

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; TESTOSTERONE;

ADULT; AGED; BLOOD; COMORBIDITY; ERECTILE DYSFUNCTION; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPOGONADISM; INCIDENCE; LIFESTYLE; MALE; METABOLIC SYNDROME X; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ONSET AGE; PHYSICAL EXAMINATION; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; AGE OF ONSET; AGED; COMBINED MODALITY THERAPY; COMORBIDITY; ERECTILE DYSFUNCTION; FOLLOW-UP STUDIES; HUMANS; HYPOGONADISM; INCIDENCE; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PHYSICAL EXAMINATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TESTOSTERONE; TREATMENT OUTCOME;

EID: 77952492855     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. US Census Bureau. International database. Table 094. Midyear population, by age and sex. Available at http://www.census. gov/population/www/projections/natdet-D1A.html.
2. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87(2):589-598.
3. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Offi cial recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002;5(2):74-86.
4. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009;55(1):121-130.
5. NIH Consensus Panel. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270(1):83-90.
6. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994:151(1):54-61.
7. Lue TF. Drug therapy: Erectile dysfunction. N Engl J Med 2000;342:1802-1813.
8. Safarinejad MR. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. Int J Impot Res 2003;15(4):246-252.
9. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004;43(2):179-184.
10. Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, Galli S, Ravagnani PM, Montorsi P. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003;44(3):360-365.
11. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004;110(2):22-26.
12. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O'Leary MP, Puppo P, Robertson C, Giuliano F. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003;44(6):637-649.
13. Brock GB. A simplifi ed approach to the treatment of erectile dysfunction-based on the Canadian Urology Association Erectile Dysfunction Guidelines. J Sex Reprod Med 2002;2:61-65.
14. Viagra product monograph, March 31, 2009
15. Cialis product monograph, March 5, 2009.
16. Levitra product monograph, August 26, 2009.
17. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafi l in the treatment of erectile dysfunction. Sildenafi l Study Group. N Eng J Med 1998:338(20): 1397-1404.
18. Porst H, Rajfer J, Casabé A, Feldman R, Ralph D, Vieiralves LF, Esler A, Wolka AM, Klise SR. Long-term safety and effi cacy of tadalafi l 5 mg dosed once daily in men with erectile dysfunction. J Sex Med 2008;5(9):2160-2169.
19. Porst H, McVary KT, Montorsi F, Sutherland P, Elion-Mboussa A, Wolka AM, Viktrup L. Effects of once-daily tadalafi l on erectile function in men with erectile dysfunction and signs and symptoms of benign prostatic hyperplasia. Eur Urol 2009;56(4):727-736.
20. Toguri A, Barkin J. Management of benign prostatic hyperplasia by family physicians. Can J Urol 2010;17(Suppl 1):26-34.
21. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;54(4): 924-931.
22. Zhang XH, Filippi S, Morelli A, Vignozzi L, Luconi M, Donati S, Forti G, Maggi M. Testosterone restores diabetes-induced erectile dysfunction and sildenafi l responsiveness in two distinct animal models of chemical diabetes. J Sex Med 2006;3(2):253-264.
23. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, Perry HM 3rd. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49(9):1239-1242. Reprinted with permission from Elsevier.
24. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2006;91(6):1995-2010.
25. Morales A, Lunenfeld B. Androgen replacement therapy in aging men with secondary hypogonadism. The Aging Male 2001;4(3):151-162.
26. Wang C, Eyre DR, Clark R, Kleinberg D, Newman C, Iranmanesh A, Veldhuis J, Dudley RE, Berman N, Davidson T, Barstow TJ, Sinow R, Alexander G, Swerdloff RS. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab 1996;81(10):3654-3662.
27. Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, Steiner B, Hull L, Callegari C, Swerdloff RS. Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab 1996;81(10):3578-3583.
28. Morgentaler A, Rhoden EL. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less. Urology 2006;68(6):1263-1267.
29. Behre HM, Bohmeyer J, Nieschlag E. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol 1994;40(3):341-349.
30. Lane BR, Stephenson AJ, Magi-Galluzzi C, Lakin MM, Klein EA. Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy. Urology 2008;72(6):1240-1245.
31. Shabsigh R, Crawford ED, Nehra A, Slawin KM. Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. Int J Impot Res 2009;21(1):9-23.
32. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112(17):2735-2752. Available at: http://circ.ahajournals. org/cgi/content/full/112/17/e285/TBL1.
33. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008;93(1):68-75.
34. Tan RS, Pu SJ. Impact of obesity on hypogonadism in the andropause. Int J Androl 2002;25(4):195-201.
35. Janowsky JS, Oviatt SK, Orwoll ES. Testosterone infl uences spatial cognition in older men. Behav Neurosci 1994;108:325-332.
36. Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991;39(8):766-771.